Track topics on Twitter Track topics that are important to you
Gendel is an innovative life sciences company formed in December 1998 to develop a drug delivery technology based on red cell sensitisation followed by the application of ultrasound. The company has made outstanding progress in the advancement of this platform technology.
Exploiting the novel concepts and technology conceived by Professor Tony McHale at the University of Ulster, the Gendel localised drug delivery system uses "loaded" and "sensitised" red blood cells to transport drugs around the body. These drugs can then be released at localised sites by the application of non-invasive low intensity ultrasound.
Science Innovatin Centre, Science Research Park, Cromore Road
Phone: 028 70 28 00 22
Fax: 028 70 28 00 97
Oxford, UK, 1 November 2017: e-Therapeutics plc (AIM: ETX), a company pioneering the use of Network-Driven Drug Discovery (NDD) to create new and better drugs, announces the appointment of Christine...
CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...
MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the developmen...
JERSEY, Channel Islands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Execut...
MosaiQ project de-risked, Verification and Validation (“V&V”) “head-to-head” studies confirm targeted concordance levels for all blood grouping assaysEuropean field trials planned to co...
JERSEY, Channel Islands, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...
MELBOURNE, Australia, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of diagn...
MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have be...
Famotidine Tablets, USP 20 mg
Facility Maintenance Instant Hand Sanitizer HS-67
Amar ICE GEL
Gendel is an innovative life sciences company formed in December 1998 to develop a drug delivery technology based on red cell sensitisation followed by the application of ultrasound. The company has m...
Gendel Limited is developing a safe novel medical device technologu for the treatment of solod cancer tumours in the absence of any drug
Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...
Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...
We have published hundreds of Gendel Limited news stories on BioPortfolio along with dozens of Gendel Limited Clinical Trials and PubMed Articles about Gendel Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Gendel Limited Companies in our database. You can also find out about relevant Gendel Limited Drugs and Medications on this site too.
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...
Radiology is the branch of medicine that studies imaging of the body; X-ray (basic, angiography, barium swallows), ultrasound, MRI, CT and PET. These imaging techniques can be used to diagnose, but also to treat a range of conditions, by allowing visuali...